Enovix Sees Unusually Large Options Volume (NASDAQ:ENVX)

Posted by on May 14th, 2026

Enovix Corporation (NASDAQ:ENVX – Get Free Report) was the recipient of unusually large options trading on Thursday. Stock investors acquired 24,162 call options on the company. This represents an increase of 48% compared to the typical daily volume of 16,356 call options.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ENVX. TD Cowen reiterated a “buy” rating on shares of Enovix in a research report on Thursday. Bank of America initiated coverage on shares of Enovix in a research note on Thursday, March 12th. They set a “neutral” rating and a $6.00 target price on the stock. Benchmark cut their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday. JPMorgan Chase & Co. lowered shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Finally, Wells Fargo & Company set a $6.00 target price on shares of Enovix in a research note on Thursday, March 12th. Seven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $12.64.

View Our Latest Stock Analysis on ENVX

Enovix Stock Down 13.6%

Shares of NASDAQ ENVX traded down $1.00 during mid-day trading on Thursday, hitting $6.30. 11,748,314 shares of the stock traded hands, compared to its average volume of 6,285,847. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34. Enovix has a 52 week low of $4.61 and a 52 week high of $16.49. The company has a market cap of $1.37 billion, a price-to-earnings ratio of -8.12 and a beta of 2.24. The stock has a fifty day moving average price of $5.78 and a 200-day moving average price of $7.15.

Trending Headlines about Enovix

Here are the key news stories impacting Enovix this week:

  • Positive Sentiment: Traders bought an unusually high amount of Enovix call options, suggesting some investors are positioning for a rebound or continued volatility in the stock. Article Title
  • Neutral Sentiment: Enovix reported first-quarter EPS of -$0.14, slightly better than expectations, and revenue of $7.6 million, with management highlighting commercial production progress on its silicon-anode smart eyewear battery and advancement toward smartphone qualification. Article Title
  • Neutral Sentiment: The company also guided second-quarter EPS to between -$0.17 and -$0.13 and revenue to $8 million-$9 million, roughly in line with expectations but not strong enough to ease concerns about near-term profitability. Article Title
  • Negative Sentiment: Several analysts cut price targets after the report, including Oppenheimer to $21 from $24, Benchmark to $15 from $25, Craig Hallum to $8 from $10, and TD Cowen to $7 from $7.50, signaling lower expectations despite mostly maintaining bullish or neutral ratings. Article Title
  • Negative Sentiment: Investors also reacted to the company’s weaker-than-hoped forward guidance, which appears to be weighing on the stock more than the slight earnings beat. Article Title

Institutional Investors Weigh In On Enovix

Several hedge funds have recently bought and sold shares of ENVX. Vanguard Group Inc. boosted its stake in Enovix by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after acquiring an additional 1,747,145 shares in the last quarter. Millennium Management LLC boosted its stake in Enovix by 1,038.9% during the third quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock worth $14,724,000 after acquiring an additional 1,347,200 shares in the last quarter. Two Sigma Investments LP boosted its stake in Enovix by 9,197.1% during the third quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock worth $11,974,000 after acquiring an additional 1,188,079 shares in the last quarter. Barclays PLC boosted its stake in Enovix by 263.1% during the fourth quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock worth $11,345,000 after acquiring an additional 1,124,480 shares in the last quarter. Finally, Electron Capital Partners LLC boosted its stake in Enovix by 13.8% during the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock worth $80,143,000 after acquiring an additional 972,103 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Read More

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.